Year: 2023

Danny-Bar-Zohar

Merck KGaA, Darmstadt, Germany, Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate

Collaboration to develop, manufacture and commercialize next-generation selective PARP1 inhibitor HRS-1167, with option to develop, manufacture and commercialize Claudin18.2 antibody-drug...

7-

【Sustainable Chic in Action】 Unveiling Hong Kong as the International Hub of Sustainable Fashion: Spectacular Two-Day Event Showcases Unmatched Lineup